Your browser doesn't support javascript.
loading
Gene expression profiling of lichenoid dermatitis immune-related adverse event from immune checkpoint inhibitors reveals increased CD14+ and CD16+ monocytes driving an innate immune response.
Curry, Jonathan L; Reuben, Alexandre; Szczepaniak-Sloane, Robert; Ning, Jing; Milton, Denái R; Lee, Chi H; Hudgens, Courtney; George, Saira; Torres-Cabala, Carlos; Johnson, Daniel; Subramanya, Sandesh; Wargo, Jennifer A; Mudaliar, Kumaran; Wistuba, Ignacio I; Prieto, Victor G; Diab, Adi; Tetzlaff, Michael T.
Affiliation
  • Curry JL; Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Reuben A; Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Szczepaniak-Sloane R; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ning J; Thoracic, Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Milton DR; Surgical Oncology and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lee CH; Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hudgens C; Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • George S; Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Torres-Cabala C; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Johnson D; Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Subramanya S; Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wargo JA; Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Mudaliar K; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wistuba II; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Prieto VG; Surgical Oncology and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Diab A; Pathology, Loyola University Medical Center, Maywood, Illinois.
  • Tetzlaff MT; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
J Cutan Pathol ; 46(9): 627-636, 2019 Sep.
Article de En | MEDLINE | ID: mdl-30883858
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Monocytes / Éruption lichénoïde / Toxidermies / Immunité innée / Antinéoplasiques Type d'étude: Observational_studies Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: J Cutan Pathol Année: 2019 Type de document: Article Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Monocytes / Éruption lichénoïde / Toxidermies / Immunité innée / Antinéoplasiques Type d'étude: Observational_studies Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: J Cutan Pathol Année: 2019 Type de document: Article Pays de publication: États-Unis d'Amérique